Showing results (61-70 of 114) with videos related to
Sort By:
Pageof 12
Scientific Reports|September 5, 2018
The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replicationTakayoshi Shirasaki, Masao Honda, Taro Yamashita, et al.The Journal of Infectious Diseases|December 2, 2015
Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular CarcinomaMasao Honda, Takayoshi Shirasaki, Takeshi Terashima, et al.Scientific Reports|December 7, 2017
Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivoMasaya Funaki, Juria Kitabayashi, Tetsuro Shimakami, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|April 7, 2009
[Two cases of a nonfunctioning pancreatic endocrine tumor found on a medical checkup]Kouki Nio, Tetsuro Shimakami, Taro Yamashita, et al.Oncotarget|February 18, 2017
Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse modelKai Takegoshi, Masao Honda, Hikari Okada, et al.Scientific Reports|March 6, 2020
A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinomaToshikatsu Tamai, Eishiro Mizukoshi, Masashi Kumagai, et al.Scientific Reports|January 9, 2015
Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and CSara R Selitsky, Jeanette Baran-Gale, Masao Honda, et al.Hepatology Communications|December 14, 2019
MicroRNA-10a Impairs Liver Metabolism in Hepatitis C Virus-Related Cirrhosis Through Deregulation of the Circadian Clock Gene Brain and Muscle Aryl Hydrocarbon Receptor Nuclear Translocator-Like 1Rika Horii, Masao Honda, Takayoshi Shirasaki, et al.Stem Cell Research & Therapy|July 6, 2025
Therapeutic effects of adipose tissue-derived mesenchymal stem cells on ER stress in a murine model of metabolic dysfunction-associated steatohepatitis: an in vivo and in vitro studyNorihiko Ogawa, Akihiro Seki, Alessandro Nasti, et al.Cancers|January 25, 2025
Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with LenvatinibTakeshi Terashima, Hidenori Kido, Noboru Takata, et al.Pageof 12